30 June 2016

Marland group moves into broker

Robert Tyerman

Former Tory treasurer Lord Marland, Carphone Warehouse co-founder David Ross and others plan to put £5 million into diversified stockbroker WH Ireland.

The powerful consortium, whose other members include investment banker Rupert Lowe, a former chairman of Southampton Leisure and director of the London International Financial Futures Exchange, has already paid £1.7 million at 100p a share for 9.9 per cent of Manchester-based WH Ireland. This move, which could have significant implications for the future of the company, is the first step in a process that the consortium hopes will bring it 26 per cent of an enlarged WH Ireland.

It follows one full takeover offer and another partial bid, both of which the company rejected. Under the purchase agreement, Lowe is to become non-executive chairman of the company, replacing former Conservative minister Sir David Trippier, and the entrepreneurial Marland, a financier and previously a leading light at Lloyd’s insurance broker Jardine Lloyd Thompson, joins the board as a non-executive director.

WH Ireland’s two largest shareholders, chief executive Laurie Beevers and managing director David Youngman, are selling parts of their holdings for £877,341 and £438,670 respectively. Subject to regulatory approval by the end of June, the consortium will buy another £1 million worth of shares, including £372,872 from Beevers, Youngman and associates, and then buy five million new shares at 100p each, taking its stake to 26 per cent.

The declared strategy is to expand WH Ireland, which made a flat £3.8 million last year on turnover up 41 per cent to £42.7 million through diversification, with possible acquisitions, following a recent £300,000 wealth management takeover, and partnerships. Beevers, who helped steer the company into corporate finance for junior resource companies from Australia and elsewhere, hopes the deal will help erase the company's 'provincial image' and enthuses that Marland and Lowe ‘are committed to supporting and developing the diversified strategy we have successfully pursued since our AIM admission in 2000’.

The shares, up 3.5p this morning to 111p and valuing WH Ireland at £18.9 million, are, in fact, 4p below the original AIM admission price, having fallen from 194p last October. Investors will hope the new backing and board members will speed recovery.

Growth Company Investor is the UK’s leading authority on small-cap and AIM companies. You can gain immediate access to all the recent share recommendations with no obligation, with a free 30-day trial. Click here to join today.

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today

 

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

 

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Avingtrans returns cash and remains a Buy

Having turned most of its market cap into cash through the sale of its aerospace division, it’s no surprise that Avingtrans (AIM: AVG) has been a very defensive stock during the recent turmoil. We now have some more details on the return of cash to shareholders which was promised as part of the disposal.

Omega investing in growth

Omega Diagnostics results looked positive and highlighted the progress being made in getting important new products to market. The investment to support those efforts will depress profits this year; but the market seems willing to look through this with Omega being a rare stock to be trading above its pre-Brexit level.

Stadium hit by profit warning

Stadium Group shares have been hit by a profit warning. This is a particular blow given the company’s progress in repositioning itself into a higher quality, design-led business.

Verona raises £42m to fund drug trials 

Verona Pharma (AIM: VRP) has raised an impressive £42 million net of costs which will fund phase II trials for its RPL554 compound. This drug targets severe respiratory diseases, in particular the 65 million worldwide sufferers from COPD (chronic obstructive pulmonary disease).

Income attractions at Belvoir

It’s fair to say that buy-to-let landlords have been under George Osborne’s cosh. He’s introduced a raised stamp duty rate and withdrawn higher-rate tax relief. However, Belvoir Lettings has seen little change in the market as far as its core lettings agency business is concerned. Furthermore, the shares have responded positively to a major acquisition which makes Belvoir the largest UK lettings agent.

Wincanton keeps on trucking

Wincanton CEO Adrian Colman feels his company is now back on an even keel after a period of fire-fighting. Debt has been brought under control, the pension deficit is being addressed, and onerous leases and contracts have been dealt with. A return to the dividend list illustrates these positive changes and the fact that management can now fully focus on growing the business.

More News